InsiderTrades

Form 4 for TYRA Tyra Biosciences, Inc.

Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0000950170-24-011880 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2024-02-06 2024-02-02+ TYRA Bensen Daniel COO S - Sale+OE $16.63 -90.8K 480.3K -16% -$1.51M
DT 2024-02-06 2024-02-02 TYRA Bensen Daniel COO M - OptEx $0.61 +25.4K 553.4K +5% +$15.5K
DT 2024-02-06 2024-02-02 TYRA Bensen Daniel COO M - OptEx $0.00 -25.4K 108.1K -19% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-06 S D 15,413 $18.09 462,568 D — — (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
2 Common Common Stock 2024-02-02 S D 2,300 $17.04 477,981 D — — (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
3 Common Common Stock 2024-02-02 S D 73,093 $16.31 480,281 D — — (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.91. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
4 Common Common Stock 2024-02-02 M A 25,393 $0.61 553,374 D — —
5 Derivative Stock Option (Right to Buy) 2024-02-02 M D 25,393 $0.00 108,110 D $0.61 · — to 2030-01-26 25,393 Common Stock (F5) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.